Diabetic Nephropathy Market to create ripples in the years to come


Diabetic nephropathy market is driven by the increasing number of patients in this regard. As per medical experts, 25% of women and 20% of men develop diabetic nephropathy. It turns out to be more common in people suffering from Type 1 Diabetes. In general terms, diabetic nephropathy refers to kidney damage resulting out of diabetes. North America rules the diabetic nephropathy market as of now; and is expected to continue with the winning streak in the years to come. This could be credited to excessive funds being diverted to healthcare; rapidly ageing population. Europe follows suit. The APAC is expected to grow at the fastest pace; India. In India, the reason for market to flourish is sedentary lifestyle.

As far as treatment is concerned, DMT (Disease Modifying Therapy) is the most known form of treatment; wherein ACE inhibitors are the fastest growing DMTs. The food and beverage sector; especially the one catering to reduced-protein diet; is also driven by diabetic nephropathy market; as such a diet is recommended for those suffering from Type 2 Diabetes. Diabetic nephropathy did affect around 6.9 million inhabitants between 2005 and 2008 in the U.S. This figure is expected to rise exponentially by 2050. One shouldn’t forget that diabetic nephropathy proves to be fatal if not checked on time. It’s the usual cause of “end-stage kidney disease”. This disease is bound to need hemodialysis. At times, kidney transplantation might also be required.

The other causes of diabetic nephropathy could be:

  • Being Hispanic, American Indian, or African-American
  • Family history of kidney-oriented diseases
  • Encountering type 1 diabetes before turning 20
  • Being obese or overweight
  • Smoking
  • Encountering other complications; such as nerve damage or ocular disease

“Stay Healthy, Eat healthy, Think Healthy” should be followed rigorously. A healthy mind will always eat healthy; and think healthy in return. This will help in checking diabetic nephropathy. Let the market grow; but better to grow to check the symptoms rather than treating the ailment.


Please enter your comment!
Please enter your name here